Phase 2 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Pregnant women who have Type 2 diabetes or gestational diabetes (diabetes that develops during pregnancy) and need insulin to control their blood sugar levels during pregnancy.
Who may not be able to join:
- People who are pregnant with more than one baby (such as twins or triplets)
- People who have Type 1 diabetes
- People under 18 years of age
- People with a known or suspected allergic reaction to NPH insulin or insulin detemir (two types of insulin medication)
- People whose unborn baby has been found to have a major physical abnormality
- People with long-term kidney or liver problems
- People who have tested positive for HIV, Hepatitis B, or Hepatitis C
- People whose doctor has already planned an early delivery due to conditions such as placenta accreta (where the placenta attaches too deeply to the uterine wall) or a previous classical caesarean section (a specific type of caesarean cut)
- People who were already using insulin to manage diabetes before becoming pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christina Han, MD, University of California, Los Angeles
Phone: 310-794-7274
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Neonatal Hypoglycemia; Prolonged neonatal hypoglycemia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.